Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
NT 10-Q

Notification that form type 10-Q will be submitted late

Quarterly Filings
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings